![](/img/cover-not-exists.png)
Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: A report from the Children's Oncology Group
Julie R. Park, Judith G. Villablanca, Wendy B. London, Robert B. Gerbing, Daphne Haas-Kogan, E. Stanton Adkins, Edward F. Attiyeh, John M. Maris, Robert C. Seeger, C. Patrick Reynolds, Katherine K. MaVolume:
52
Year:
2009
Language:
english
Pages:
7
DOI:
10.1002/pbc.21784
File:
PDF, 104 KB
english, 2009